Search alternatives:
significant use » significant cause (Expand Search), significant i.e (Expand Search), significantly used (Expand Search)
mean decrease » a decrease (Expand Search)
non decrease » nn decrease (Expand Search), point decrease (Expand Search), note decreased (Expand Search)
use based » rule based (Expand Search), case based (Expand Search), one based (Expand Search)
Showing 161 - 180 results of 134,500 for search '(( significant use based ) OR ( significant ((non decrease) OR (mean decrease)) ))', query time: 1.30s Refine Results
  1. 161
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 162
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 163
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 164
    PRISMA flow chart.

    PRISMA flow chart. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 165
    Summary of clinical efficacy of relevant PTSD treatments.

    Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 166
    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.

    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 167
    Fig 3 -

    Fig 3 - by Calvin P. Philp (12095878)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  8. 168
    IMP-1088 decreases infectivity of progeny VACV particles.

    IMP-1088 decreases infectivity of progeny VACV particles. by Lalita Priyamvada (421536)

    Published 2022
    “…Yields plotted for both treatments as pfu/mL. Statistical significance determined using an unpaired t test; p > 0.05.…”
    Save to List
    Saved in:
  9. 169
    Boruta, random forest model variable significance and ranking for sound pressure levels and anthropogenic noise detections.

    Boruta, random forest model variable significance and ranking for sound pressure levels and anthropogenic noise detections. by Lindsey Transue (15322306)

    Published 2023
    “…Bars represent the significance (mean Z-score) of each variable from the Boruta wrapper algorithm based on a random forest model. …”
    Save to List
    Saved in:
  10. 170
    Comparisons of muscle strength between COPD and the reference group, mean of adjusted muscle strength during maximum isometric contraction.

    Comparisons of muscle strength between COPD and the reference group, mean of adjusted muscle strength during maximum isometric contraction. by Viktor Strandkvist (9667130)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  11. 171
    Methodological items for non-randomized studies (MINORS).

    Methodological items for non-randomized studies (MINORS). by Solima Sabeel (9545738)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 172
    Changes in connectivity of the mPFC among responders and non-responders.

    Changes in connectivity of the mPFC among responders and non-responders. by Karel Joineau (21799908)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 173
    Time-based splitting strategy and forecast horizons.

    Time-based splitting strategy and forecast horizons. by Thierry Jean (20691795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 174
    Impact of deforestation and subsequent land-use diversity on the carbon and nitrogen pool (CPI and NPI) and management indices (CMI), calculated based on active carbon (AC), fulvic acid (FA), humic acid (HA), and glucose equivalent total non-humic carbon (NH) pools at different soil depths.

    Impact of deforestation and subsequent land-use diversity on the carbon and nitrogen pool (CPI and NPI) and management indices (CMI), calculated based on active carbon (AC), fulvic... by Emmanuel Amoakwah (13228938)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  15. 175
    Additional file 3 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study

    Additional file 3 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

    Published 2025
    Save to List
    Saved in:
  16. 176
    Mean density (g/m<sup>2</sup>) and whole survey area fish abundance (kg) estimated using mean <i>Sa</i> and set net catch ratio.

    Mean density (g/m<sup>2</sup>) and whole survey area fish abundance (kg) estimated using mean <i>Sa</i> and set net catch ratio. by Yanhui Zhu (6697751)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  17. 177
    The forest plots of pooled estimates of standardized mean differences of circulating apelin (A), apelin/HDL-c (B), apelin/LDL-c (C), apelin/triglycerides (D), and apelin/total cholesterol (E) levels between cases with CVDs and controls.

    The forest plots of pooled estimates of standardized mean differences of circulating apelin (A), apelin/HDL-c (B), apelin/LDL-c (C), apelin/triglycerides (D), and apelin/total chol... by Hamed Akbari (8119361)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  18. 178
    Additional file 7 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study

    Additional file 7 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

    Published 2025
    Save to List
    Saved in:
  19. 179
    Additional file 11 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study

    Additional file 11 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

    Published 2025
    Save to List
    Saved in:
  20. 180
    Additional file 10 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study

    Additional file 10 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

    Published 2025
    Save to List
    Saved in:

Search Tools: